Trademark: RECOMBUMIN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for RECOMBUMIN
We do not have any records of a proof of use for RECOMBUMIN at this moment.
Possible trademark infringements of RECOMBUMIN
Basic Information about RECOMBUMIN
- Serial Number
- 75592289
- Filing Date
- 19 Nov 1998
- Registration Number
- 2523050
- Registration Date
- 25 Dec 2001
- Mark Drawing Code
- 1
Classifications
Declare the trademark use of RECOMBUMIN on the blockchain with WikiTrademarks.io.
- First use of RECOMBUMIN anywhere
- RECOMBUMIN was first used on 26 Oct 1999 for the primary classification of goods and services, international, 001 (Chemicals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of RECOMBUMIN anywhere
- RECOMBUMIN was first used on 26 Oct 1999 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns RECOMBUMIN?
1. ALBUMEDIX LTD NOTTINGHAM
2. ALBUMEDIX A/S LYNGBY
3. ALBUMEDIX A/S LYNGBY
4. NOVOZYMES BIOPHARMA DK A/S BAGSVAERD
5. NOVOZYMES BIOPHARMA UK LIMITED NOTTINGHAM, NG7 1FD
6. NOVOZYMES DELTA LIMITED NOTTINGHAM
7. Delta Biotechnology Limited Nottingham
8. Delta Biotechnology Limited Nottingham
9. Delta Biotechnology Limited Nottingham
Correspondent
- Victoria Friedman
- Dennemeyer & Associates, LLC
- 2 North Riverside Plaza, Suite 1500
- CHICAGO IL 60606
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io